Armodafinil 150 MG Oral Tablet — RxCUI 724859
RxNorm drug concept · Semantic clinical drug
RxCUI 724859
Semantic clinical drug · SCD
● Current RxNorm concept 31 FDA products
49 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI724859
Official nameArmodafinil 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped31
Package NDCs mapped49
Reported Medicaid activity (SDUD)35,749 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Armodafinil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It promotes wakefulness, so yes, it has some similarities to stimulants like amphetamine in terms of keeping you alert. But its mechanism is different — it mainly works through the...
- What exactly does armodafinil do — is it like a stimulant?
- For sleep apnea or narcolepsy, take it once in the morning. For shift work disorder, take it about an hour before your shift starts. Food won't significantly change how much of the...
- When should I take it, and does it matter if I eat first?
🕸️ Concept Web — How Armodafinil 150 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Armodafinil 150 MG Oral Tablet
RxCUI 724859 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Armodafinil
641465IN
-
Armodafinil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nuvigil
710995BN
-
Nuvigil
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Armodafinil Oral Tablet
724858SCDF -
Armodafinil Oral Product
1158263SCDG -
Armodafinil Pill
1158264SCDG -
Armodafinil Oral Tablet [Nuvigil]
805658SBDF -
Nuvigil Oral Product
1179387SBDG -
Nuvigil Pill
1179388SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Armodafinil Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Armodafinil 150 MG
724857SCDC -
Armodafinil 150 MG Oral Tablet [Nuvigil]
805659SBD -
Armodafinil 150 MG [Nuvigil]
805657SBDC
-
Armodafinil 150 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Armodafinil 150 MG
SCDC · 724857 -
Armodafinil Oral Tablet
SCDF · 724858 -
Armodafinil Oral Product
SCDG · 1158263 -
Armodafinil Pill
SCDG · 1158264
Brand-Name Concepts
-
Armodafinil 150 MG Oral Tablet [Nuvigil]
SBD · 805659 -
Armodafinil 150 MG [Nuvigil]
SBDC · 805657 -
Armodafinil Oral Tablet [Nuvigil]
SBDF · 805658 -
Nuvigil Oral Product
SBDG · 1179387 -
Nuvigil Pill
SBDG · 1179388 -
Nuvigil
BN · 710995
📦 FDA Products & Package NDCs
31 products · 49 package NDCs
49 package NDCs map to RxCUI 724859 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-3090-56 | 30 TABLET in 1 BOTTLE (0093-3090-56) | Armodafinil | Teva Pharmaceuticals USA, Inc. | 2016-11-29 |
| 00093-3092-56 | 30 TABLET in 1 BOTTLE (0093-3092-56) | Armodafinil | Teva Pharmaceuticals USA, Inc. | 2016-11-29 |
| 00093-3094-56 | 30 TABLET in 1 BOTTLE (0093-3094-56) | Armodafinil | Teva Pharmaceuticals USA, Inc. | 2016-11-29 |
| 00378-3431-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-3431-93) | Armodafinil | Mylan Pharmaceuticals Inc. | 2016-06-01 |
| 00378-3432-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-3432-93) | Armodafinil | Mylan Pharmaceuticals Inc. | 2016-06-01 |
| 00378-3433-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-3433-93) | Armodafinil | Mylan Pharmaceuticals Inc. | 2016-06-01 |
| 00781-8029-31 | 30 TABLET in 1 BOTTLE (0781-8029-31) | Armodafinil | Sandoz Inc | 2016-12-01 |
| 00781-8037-31 | 30 TABLET in 1 BOTTLE (0781-8037-31) | Armodafinil | Sandoz Inc | 2016-12-01 |
| 00781-8045-31 | 30 TABLET in 1 BOTTLE (0781-8045-31) | Armodafinil | Sandoz Inc | 2016-12-01 |
| 00781-8053-31 | 30 TABLET in 1 BOTTLE (0781-8053-31) | Armodafinil | Sandoz Inc | 2016-12-01 |
| 60429-0001-30 | 30 TABLET in 1 BOTTLE (60429-001-30) | Nuvigil | Golden State Medical Supply, Inc. | 2025-07-30 |
| 60429-0002-30 | 30 TABLET in 1 BOTTLE (60429-002-30) | Nuvigil | Golden State Medical Supply, Inc. | 2025-07-30 |
| 60429-0003-30 | 30 TABLET in 1 BOTTLE (60429-003-30) | Nuvigil | Golden State Medical Supply, Inc. | 2025-07-30 |
| 60429-0004-30 | 30 TABLET in 1 BOTTLE (60429-004-30) | Nuvigil | Golden State Medical Supply, Inc. | 2025-07-30 |
| 60505-4846-03 | 30 TABLET in 1 BOTTLE (60505-4846-3) | Nuvigil | Apotex Corp. | 2025-08-31 |
| 60505-4847-03 | 30 TABLET in 1 BOTTLE (60505-4847-3) | Nuvigil | Apotex Corp. | 2025-08-31 |
| 60505-4849-03 | 30 TABLET in 1 BOTTLE (60505-4849-3) | Nuvigil | Apotex Corp. | 2025-08-31 |
| 60505-4850-03 | 30 TABLET in 1 BOTTLE (60505-4850-3) | Nuvigil | Apotex Corp. | 2025-08-31 |
| 63459-0215-30 | 30 TABLET in 1 BOTTLE (63459-215-30) | Nuvigil | Cephalon, LLC | 2011-01-03 |
| 65862-0805-05 | 500 TABLET in 1 BOTTLE (65862-805-05) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0805-30 | 30 TABLET in 1 BOTTLE (65862-805-30) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0805-60 | 60 TABLET in 1 BOTTLE (65862-805-60) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0806-05 | 500 TABLET in 1 BOTTLE (65862-806-05) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0806-30 | 30 TABLET in 1 BOTTLE (65862-806-30) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0806-60 | 60 TABLET in 1 BOTTLE (65862-806-60) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0807-05 | 500 TABLET in 1 BOTTLE (65862-807-05) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0807-30 | 30 TABLET in 1 BOTTLE (65862-807-30) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0807-60 | 60 TABLET in 1 BOTTLE (65862-807-60) | Armodafinil | Aurobindo Pharma Limited | 2018-03-06 |
| 65862-0998-30 | 30 TABLET in 1 BOTTLE (65862-998-30) | Armodafinil | Aurobindo Pharma Limited | 2018-12-07 |
| 68788-7880-03 | 30 TABLET in 1 BOTTLE (68788-7880-3) | Armodafinil | Preferred Pharmaceuticals Inc. | 2021-03-08 |
| 68788-7880-06 | 60 TABLET in 1 BOTTLE (68788-7880-6) | Armodafinil | Preferred Pharmaceuticals Inc. | 2021-03-08 |
| 68788-7880-09 | 90 TABLET in 1 BOTTLE (68788-7880-9) | Armodafinil | Preferred Pharmaceuticals Inc. | 2021-03-08 |
| 69339-0177-03 | 30 TABLET in 1 BOTTLE (69339-177-03) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0177-10 | 1000 TABLET in 1 BOTTLE (69339-177-10) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0178-03 | 30 TABLET in 1 BOTTLE (69339-178-03) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0178-10 | 1000 TABLET in 1 BOTTLE (69339-178-10) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0179-03 | 30 TABLET in 1 BOTTLE (69339-179-03) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0179-10 | 1000 TABLET in 1 BOTTLE (69339-179-10) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0180-03 | 30 TABLET in 1 BOTTLE (69339-180-03) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 69339-0180-05 | 500 TABLET in 1 BOTTLE (69339-180-05) | Armodafinil | Natco Pharma USA LLC | 2023-03-23 |
| 71335-1193-01 | 30 TABLET in 1 BOTTLE (71335-1193-1) | Armodafinil | Bryant Ranch Prepack | 2019-04-16 |
| 71335-1193-02 | 28 TABLET in 1 BOTTLE (71335-1193-2) | Armodafinil | Bryant Ranch Prepack | 2024-04-03 |
| 71335-1193-03 | 90 TABLET in 1 BOTTLE (71335-1193-3) | Armodafinil | Bryant Ranch Prepack | 2024-04-03 |
| 71335-1308-01 | 30 TABLET in 1 BOTTLE (71335-1308-1) | Armodafinil | Bryant Ranch Prepack | 2019-08-23 |
| 71335-1308-02 | 28 TABLET in 1 BOTTLE (71335-1308-2) | Armodafinil | Bryant Ranch Prepack | 2019-08-23 |
| 71335-1308-03 | 90 TABLET in 1 BOTTLE (71335-1308-3) | Armodafinil | Bryant Ranch Prepack | 2019-08-23 |
| 71335-2991-01 | 30 TABLET in 1 BOTTLE (71335-2991-1) | Armodafinil | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2991-02 | 28 TABLET in 1 BOTTLE (71335-2991-2) | Armodafinil | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2991-03 | 90 TABLET in 1 BOTTLE (71335-2991-3) | Armodafinil | Bryant Ranch Prepack | 2026-02-04 |
Observed labelers:
Aurobindo Pharma Limited (10) ·
Bryant Ranch Prepack (9) ·
Natco Pharma USA LLC (8) ·
Apotex Corp. (4) ·
Golden State Medical Supply, Inc. (4) ·
Sandoz Inc (4)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.